These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791 [TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. Koduru PR; Offit K; Filippa DA Oncogene; 1989 Jul; 4(7):929-34. PubMed ID: 2787901 [TBL] [Abstract][Full Text] [Related]
24. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Specht K; Haralambieva E; Bink K; Kremer M; Mandl-Weber S; Koch I; Tomer R; Hofler H; Schuuring E; Kluin PM; Fend F; Quintanilla-Martinez L Blood; 2004 Aug; 104(4):1120-6. PubMed ID: 15090460 [TBL] [Abstract][Full Text] [Related]
25. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Komatsu H; Iida S; Yamamoto K; Mikuni C; Nitta M; Takahashi T; Ueda R; Seto M Blood; 1994 Aug; 84(4):1226-31. PubMed ID: 8049438 [TBL] [Abstract][Full Text] [Related]
26. Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. de Boer CJ; Loyson S; Kluin PM; Kluin-Nelemans HC; Schuuring E; van Krieken JH Cancer Res; 1993 Sep; 53(18):4148-52. PubMed ID: 8364907 [TBL] [Abstract][Full Text] [Related]
27. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713 [TBL] [Abstract][Full Text] [Related]
28. Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization. de Boer CJ; Vaandrager JW; van Krieken JH; Holmes Z; Kluin PM; Schuuring E Oncogene; 1997 Sep; 15(13):1599-603. PubMed ID: 9380412 [TBL] [Abstract][Full Text] [Related]
29. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Fonseca R; Blood EA; Oken MM; Kyle RA; Dewald GW; Bailey RJ; Van Wier SA; Henderson KJ; Hoyer JD; Harrington D; Kay NE; Van Ness B; Greipp PR Blood; 2002 May; 99(10):3735-41. PubMed ID: 11986230 [TBL] [Abstract][Full Text] [Related]
30. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma. Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483 [TBL] [Abstract][Full Text] [Related]
31. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Chesi M; Kuehl WM; Bergsagel PL Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795 [TBL] [Abstract][Full Text] [Related]
32. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma. Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791 [TBL] [Abstract][Full Text] [Related]
33. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Williams ME; Swerdlow SH; Rosenberg CL; Arnold A Cancer Res; 1992 Oct; 52(19 Suppl):5541s-5544s. PubMed ID: 1394169 [TBL] [Abstract][Full Text] [Related]
34. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC. Galiègue-Zouitina S; Collyn-d'Hooghe M; Denis C; Mainardi A; Hildebrand MP; Tilly H; Bastard C; Kerckaert JP Genes Chromosomes Cancer; 1994 Dec; 11(4):246-55. PubMed ID: 7533528 [TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in patients with multiple myeloma. Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187 [TBL] [Abstract][Full Text] [Related]
36. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315 [TBL] [Abstract][Full Text] [Related]
37. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628 [TBL] [Abstract][Full Text] [Related]
38. [Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation]. Iida S; Seto M; Yamamoto K; Ueda R Nihon Rinsho; 1992 Jun; 50(6):1374-9. PubMed ID: 1518159 [TBL] [Abstract][Full Text] [Related]
39. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Jhang JS; Narayan G; Murty VV; Mansukhani MM Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886 [TBL] [Abstract][Full Text] [Related]
40. Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Meeus P; Stul MS; Mecucci C; Cassiman JJ; Van den Berghe H Cancer Genet Cytogenet; 1995 Aug; 83(1):25-7. PubMed ID: 7656199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]